Avivagen Inc (TSE:VIV) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Avivagen Inc., a life sciences company specializing in health and performance products for animals, has declared bankruptcy due to its inability to secure additional capital or a strategic transaction after a previously signed non-binding LOI with an international conglomerate fell through. The Ottawa-based company had sought to maximize value for stakeholders by exploring various strategic alternatives, but current market conditions have left it with no viable options, leading to a voluntary assignment into bankruptcy under Canada’s Bankruptcy and Insolvency Act.
For further insights into TSE:VIV stock, check out TipRanks’ Stock Analysis page.